Our development projects

Macrobiome Therapeutics is developing novel therapeutics that will inhibit chronic debilitating diseases with limited efficacious treatment options with a primary focus on inflammatory bowel disease. Our proprietary secretome library is a rich source of bio-active molecules that is being mined for immunomodulatory activities across an array of immune and cell-based assays.